πŸ‡ΊπŸ‡Έ FDA
Patent

US 11708352

Anti-cancer compounds

granted A61KA61K31/502A61P

Quick answer

US patent 11708352 (Anti-cancer compounds) held by The Regents of the University of California expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/502, A61P, A61P35/00